KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Illumina (ILMN) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Illumina's Cash & Equivalents rose 2082.85% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 2082.85%. This contributed to the annual value of $1.1 billion for FY2024, which is 753.82% up from last year.
  • As of Q3 2025, Illumina's Cash & Equivalents stood at $1.0 billion, which was up 2082.85% from $934.0 million recorded in Q2 2025.
  • Illumina's 5-year Cash & Equivalents high stood at $4.4 billion for Q2 2021, and its period low was $869.0 million during Q3 2024.
  • Over the past 5 years, Illumina's median Cash & Equivalents value was $1.1 billion (recorded in 2024), while the average stood at $1.5 billion.
  • Per our database at Business Quant, Illumina's Cash & Equivalents soared by 13706.21% in 2021 and then tumbled by 6952.4% in 2022.
  • Over the past 5 years, Illumina's Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then decreased by 7.41% to $1.0 billion in 2022, then rose by 4.8% to $1.0 billion in 2023, then rose by 7.54% to $1.1 billion in 2024, then decreased by 6.83% to $1.0 billion in 2025.
  • Its Cash & Equivalents stands at $1.0 billion for Q3 2025, versus $934.0 million for Q2 2025 and $1.1 billion for Q1 2025.